EVAX
Income statement / Annual
Last year (2024), Evaxion Biotech A/S's total revenue was $3.34 M,
an increase of 4,480.82% from the previous year.
In 2024, Evaxion Biotech A/S's net income was -$10.57 M.
See Evaxion Biotech A/S,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$3.34 M |
$73.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$80.98 K
|
$73.93 K
|
| Gross Profit |
$3.34 M
|
$73.00 K
|
$0.00
|
$0.00
|
$0.00
|
-$80.98 K
|
-$73.93 K
|
| Gross Profit Ratio |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$10.46 M
|
$11.92 M
|
$17.06 M
|
$19.58 M
|
$11.70 M
|
$8.65 M
|
$3.73 M
|
| General & Administrative Expenses |
$7.32 M
|
$10.08 M
|
$8.06 M
|
$6.18 M
|
$5.67 M
|
$0.00
|
$1.88 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.32 M
|
$10.08 M
|
$8.06 M
|
$6.18 M
|
$5.67 M
|
$2.63 M
|
$1.88 M
|
| Other Expenses |
$302.00 K
|
$275.00 K
|
$144.00 K
|
$71.00 K
|
-$800.00 K
|
$0.00
|
$15.00 K
|
| Operating Expenses |
$18.08 M
|
$22.27 M
|
$25.26 M
|
$25.83 M
|
$16.57 M
|
$11.28 M
|
$5.63 M
|
| Cost And Expenses |
$18.08 M
|
$22.27 M
|
$25.26 M
|
$25.83 M
|
$16.57 M
|
$11.36 M
|
$5.63 M
|
| Interest Income |
$254.00 K
|
$154.00 K
|
$2.83 M
|
$2.04 M
|
$216.00 K
|
$9.00 K
|
$2.00 K
|
| Interest Expense |
$962.00 K
|
$897.00 K
|
$1.51 M
|
$915.00 K
|
$223.00 K
|
$1.22 M
|
$698.00 K
|
| Depreciation & Amortization |
$607.00 K
|
$615.00 K
|
$571.00 K
|
$344.00 K
|
$105.00 K
|
$80.98 K
|
$73.93 K
|
| EBITDA |
-$9.79 M |
-$21.40 M |
-$22.57 M |
-$24.21 M |
-$16.46 M |
-$11.90 M |
-$6.18 M |
| EBITDA Ratio |
-2.93
|
-293.19
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-4.41
|
-304.07
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$3.38 M
|
-$718.00 K
|
$1.32 M
|
$1.12 M
|
-$7.00 K
|
-$656.87 K
|
-$636.93 K
|
| Income Before Tax |
-$11.36 M
|
-$22.92 M
|
-$23.94 M
|
-$24.71 M
|
-$16.58 M
|
-$12.02 M
|
-$6.27 M
|
| Income Before Tax Ratio |
-3.4
|
-313.9
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$788.00 K
|
-$790.00 K
|
-$772.00 K
|
-$178.00 K
|
-$1.56 M
|
-$824.84 K
|
-$735.00 K
|
| Net Income |
-$10.57 M
|
-$22.13 M
|
-$23.17 M
|
-$24.53 M
|
-$15.02 M
|
-$11.19 M
|
-$5.54 M
|
| Net Income Ratio |
-3.16
|
-303.08
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-9.8 |
-32.4 |
-39.2 |
-50.4 |
-37 |
-27.6 |
-11.52 |
| EPS Diluted |
-9.8 |
-32.4 |
-39.2 |
-50.4 |
-37 |
-27.6 |
-11.52 |
| Weighted Average Shares Out |
$1.07 M
|
$683.40 K
|
$590.97 K
|
$487.33 K
|
$404.97 K
|
$404.97 K
|
$479.97 K
|
| Weighted Average Shares Out Diluted |
$1.07 M
|
$683.40 K
|
$590.97 K
|
$487.33 K
|
$404.97 K
|
$404.97 K
|
$479.97 K
|
| Link |
|
|
|
|
|
|
|
